Gina Wang

Managing Director and Senior Equity Research Analyst at Barclays PLC

Gena Wang is a Managing Director and Senior Equity Research Analyst at Barclays PLC, specializing in the healthcare sector with a primary focus on biotechnology and drug manufacturing companies. She covers leading biopharma firms such as Moderna, Alnylam Pharmaceuticals, Sarepta Therapeutics, and PTC Therapeutics, and her performance metrics include covering approximately 60 stocks with a success rate between 38% and 45% and an average return per rating ranging from 0.6% to 3.4%. Wang operates out of New York, joined Barclays in 2015, and has established herself among the top analysts in her field, at times ranking in the top quartile by platforms such as TipRanks and StockAnalysis. She holds professional credentials with relevant FINRA registrations and securities licenses, recognized for her in-depth sector expertise and for generating standout returns on selected calls, such as a +449% return on Moderna.